Therapist Insights / Therapy Value
Is therapy worth it, and worth the hour it takes?
Most people asking whether therapy is worth it are not really asking about the fee. They are asking whether one hour a week, taken out of a calendar that has no spare hours in it, returns anything they can measure. The honest answer has a yes in it, a no in it, and a checkpoint where you find out which one you got.
THE QUICK TAKEAWAY
Psychotherapy works for a substantial minority of the people who receive it and does very little for a large minority. Across 228 randomized trials, Cuijpers and colleagues found that 41 percent of adults treated for depression responded within about two months, against 17 percent receiving usual care, with roughly one third reaching remission. CEREVITY clinicians treat that as the honest starting point rather than a sales figure. Therapy is worth it when three things are true at once: a problem specific enough to name, a clinician who genuinely fits, and a review point where you check the return instead of assuming it.
§01 / 09 / Definition
Does therapy work, and how well?
Psychotherapy produces a real but partial effect. Across 228 randomized trials of treatment for adult depression, 41 percent of treated people responded within about two months, against 16 to 17 percent on a waitlist or in usual care, and about one third reached remission. Therapy therefore works well for many high earners and not for all of them.
Start with the number nobody in this industry likes to lead with. In a 2021 meta-analysis of 228 randomized trials, Pim Cuijpers and colleagues pooled the proportion of adults with depression who actually got better rather than the usual effect sizes, and reported a response rate of 41 percent at roughly two months for psychotherapy, against 17 percent for care as usual and 16 percent for a waitlist. Remission, the stricter standard, was reached by about a third. The number needed to treat was 5.3 against usual care: treat five people and one more of them gets better than would have anyway. The authors' own conclusion is blunt, and worth reading twice before anyone quotes the cheerful version of this literature: psychotherapies may be effective compared with control conditions, but more than half of patients receiving therapy do not respond and only one third remit. That is what the evidence supports. It is a good treatment with a modest hit rate, not a solved problem, and a reader who was told otherwise has been sold something.
Five objections that keep capable people out of the room
The hour is the scarce resource
For someone whose diary is booked in fifteen-minute blocks, the fee is trivial and the hour is not. A weekly session is roughly fifty hours a year, plus the travel of getting your head into it and back out. That is the real price, and it deserves a real answer.
It has never been necessary before
People who have succeeded without help reasonably infer that help is not the variable. The inference holds until the method that got you here stops working, which is usually the moment the search happens.
It sounds self-indulgent
Treatment for something you can still function through feels like a luxury purchase rather than a medical one. Functioning is not the same as being well, and the gap between the two is where most of this work happens.
The output is unmeasurable
Anyone who runs on metrics distrusts a service with no scoreboard. Validated sessional measures exist and are used in ordinary clinical practice, so the absence of a scoreboard is a choice, not a property of therapy.
Nobody has told me when to stop
An open-ended commitment with no defined end is the one purchase a disciplined buyer never makes. A course of treatment with a stated focus and a review date is a very different proposition from an indefinite standing appointment.
▶ Research
The National Institute for Health and Care Excellence, which issues treatment guidance for the health service in England, tells clinicians to "review how well the treatment is working with the person between 2 and 4 weeks after starting treatment" and to "consider routine outcome monitoring (using appropriate validated sessional outcome measures, for example PHQ-9)". Its guideline also puts a number on the length of a course: individual cognitive behavioural therapy for a new episode of more severe depression "usually consists of 16 regular sessions". Read as a consumer rather than as a clinician, that is the most useful thing in the guideline literature. A course of therapy is not an open-ended leap of faith. It has an early review point and a rough length, and if nothing has moved by the review point, that is information you paid for rather than a failure you should sit through quietly.1
What the numbers do and do not mean
An average is not a promise
A 41 percent response rate is a property of a population, not of you. It tells you the odds are good enough to justify a defined trial of treatment. It does not tell you that your outcome is already decided, in either direction.
The average hides two different people
Pooled results in this literature carry high heterogeneity and considerable risk of bias in the underlying trials, which the authors say plainly. Some people improve substantially, some not at all, and the headline number is the blend of both.
Doing nothing is not the zero line
Waitlist and usual-care groups improve too, at 16 to 17 percent. The relevant comparison is never treatment against a frozen baseline. It is treatment against the version of the next twelve months you would have had anyway.
Who carries the cost while you decide
The cost of waiting is real, it just does not appear on a statement. It is paid in three places, and only one of them is you.
You
Untreated burnout and low mood degrade sleep, attention and judgment first, which are precisely the faculties a high earner is paid for. The bill arrives as worse decisions rather than as symptoms.
The people who report to you
Irritability and withdrawal at the top of an organisation are read as signals by everyone below. Teams reorganise themselves around a leader's mood long before anyone names what is happening.
The people at home
The partner and children of someone running on empty absorb the difference between the person at work and the person who comes home. That transfer is usually the reason people finally start.
§02 / 09 / Telehealth
Is therapy worth the money?
Therapy is worth the money when the problem it targets already costs more than the fee. For high earners that cost usually appears as degraded judgment, lost sleep, avoided decisions and strained relationships rather than as a line item. CEREVITY clinicians ask what the current situation is costing before anyone discusses what treatment costs.
One place where the whole picture is admissible
Senior people distribute their reality: the board hears one version, the team another, the partner a third. Nobody holds all of it, which is why nobody can help with all of it. A clinician is the one party who gets the unedited version and is qualified to do something with it.
Decisions get cheaper
Most of the value people report is not emotional relief but decision quality. Rumination, avoidance and reactivity all tax judgment, and reducing them shows up in fewer reversals, fewer late-night escalations and fewer expensive decisions made at nine in the evening. For some readers this is already the point at which too many decisions stops being a scheduling problem and becomes a clinical one.
The compounding stops
Burnout, anxiety and low mood are progressive when untreated. The realistic comparison is not this year with therapy against this year without it, but three years of treated trajectory against three years of the current one. Anticipatory dread before board meetings, funding rounds and earnings calls follows the same curve, which is why when the stakes are real and the anxiety is too is treated as a clinical target rather than as nerves.
§03 / 09 / Mechanism
When therapy is not the right spend right now.
Therapy is not the right spend for three groups of people: those whose problem is situational and already resolving, those who want advice rather than treatment, and those whose first need is medical. High earners in the first group frequently improve on their own within weeks and would be paying for a recovery that was coming anyway.
The first group is the situational one. A brutal quarter, a deal that collapsed, a bereavement in its early weeks, a move: these produce symptoms that look exactly like the ones treatment targets, and a large share of them resolve without any treatment at all. The waitlist and usual-care arms in the depression literature are the evidence for this, running at 16 to 17 percent response over two months with no intervention beyond time. If your sleep, appetite and interest are already trending back toward normal, and the thing that caused the drop has ended, the honest answer is to wait four to six weeks and see. Set the date. If the trend has stalled or reversed by then, that is a different conversation and a much better use of a first session.
The second group wants advice, and therapy is an expensive and slow way to buy an opinion. If the question is whether to take the offer, restructure the team or sell the business, a clinician is not the right instrument. Where treatment does become relevant is when the same decision has been open for eight months, or when every option gets modelled at three in the morning and none of them ever gets chosen. That is not a strategy problem wearing a clinical mask. It is a clinical problem wearing a strategy mask, and it is worth being honest with yourself about which one you have.
The third group needs a physician first. Exhaustion, low mood, poor concentration and flattened motivation have well-known medical drivers, including sleep disorders, thyroid disease and anaemia, and no amount of skilled psychological work will move a symptom whose cause sits in the blood or the airway. Anyone whose main complaint is physical exhaustion should be examined by their doctor before or alongside starting treatment. And anyone in immediate danger should not be reading an article about value. The crisis resources at the foot of this page exist for that, and they are free.
► Standard advice vs. CEREVITY's approach
Standard therapy
"Book an open-ended weekly slot and hope it accumulates into something"
CEREVITY
"Name the target, agree a length, and set the date you will judge it on"
Standard therapy
"Judge the first clinician you meet by whether the conversation felt pleasant"
CEREVITY
"Judge them on whether they can state what they are treating and how"
Standard therapy
"Stay a year with someone who is not a fit because leaving feels rude"
CEREVITY
"Change clinician at the review point; fit is the strongest single predictor there is"
| Standard insurance-based therapy | CEREVITY's specialized approach |
|---|---|
| "Book an open-ended weekly slot and hope it accumulates into something" | "Name the target, agree a length, and set the date you will judge it on" |
| "Judge the first clinician you meet by whether the conversation felt pleasant" | "Judge them on whether they can state what they are treating and how" |
| "Stay a year with someone who is not a fit because leaving feels rude" | "Change clinician at the review point; fit is the strongest single predictor there is" |
A break from the page
Decide it like a purchase, not like a leap of faith.
A defined problem, a stated method and a review date turn an open-ended commitment into something a disciplined buyer can actually evaluate. CEREVITY is a nationwide network of independent licensed clinicians working on a private-pay basis, and you can read how the clinical model is structured before you commit an hour to anything. Call (562) 295-6650 or send a private inquiry.
§04 / 09 / Cases
Common challenges we address.
The executive who bought a year of pleasant conversations
The patternFifty weeks of sessions that were interesting, humane and consistently agreeable, with no stated target and no measure. The relationship was good. The treatment never started, because nothing was ever named as the thing being treated.
What we addressThe repair is unglamorous: name one primary problem, agree the approach that has evidence behind it, and set an explicit review at four to six sessions. If the presenting problem is sustained exhaustion rather than low mood, how burnout gets addressed when stepping back from the role is not an option is the question worth putting to a clinician in the first session.
The high earner who never got past the first clinician
The patternA first match that was competent but wrong, tolerated for a year out of politeness and a suspicion that changing would look like avoidance. Progress flat throughout, and a conclusion drawn about therapy that was really a conclusion about one pairing.
What we addressFit is not a soft variable. Across 295 studies and more than 30,000 patients, the alliance between client and clinician correlates with outcome at r = .278, which is one of the most consistent findings in the field. Raising the mismatch at the review point is standard clinical practice, and a good clinician will help you make the change rather than take it personally.
§05 / 09 / Methods
Evidence-based treatment approaches.
CEREVITY clinicians select an approach that fits the presenting problem rather than applying one method to everything, because the outcome literature finds few reliable differences between bona fide therapies and large differences in how well a given method suits a given problem.
Cognitive Behavioral Therapy (CBT)
Structured, time-limited and the most heavily trialled approach in the depression literature, with a response rate of 42 percent in the pooled analysis. Its homework demand suits people who like a method they can practise between sessions.
Behavioral Activation (BA)
Targets the withdrawal loop directly by rebuilding the activities that carry mood, and returned the highest single response rate, 46 percent, of the therapies compared. Often the right first choice when energy and motivation are the presenting complaint.
Acceptance and Commitment Therapy (ACT)
Builds the capacity to act on what matters while discomfort is still present, which is the specific skill a high performer needs when waiting to feel better is not an option the calendar allows.
Psychodynamic therapy
Works on the longer-standing patterns around achievement, worth and control that keep reproducing the same situation in a new company, including the fear of being found out, treated clinically. Slower to show movement, and the right tool when the problem has recurred across decades rather than months.
Trauma-focused approaches
Where a specific event drives the picture, structured trauma treatment addresses it directly rather than managing the symptoms around it. This is where a longer session block usually earns its place.
§06 / 09 / Investment
Understanding the investment in private-pay care.
Private-pay, nationwide, and priced as a defined course of work
At CEREVITY, our online individual therapy sessions are structured as a direct investment in your mental agility and overall well-being. The investment includes:
- Licensed mental health professional specializing in private-pay therapy for demanding careers
- Evidence-based, one-on-one approaches proven effective for burnout, anxiety, and persistent low mood
- Flexible online scheduling including evenings and weekends
- Complete privacy with no insurance involvement or red tape
- High earners deciding whether therapy is worth the money and the hour expertise and understanding
- Outcome tracking and progress measurement
The cost of whether therapy is worth it going unaddressed
Consider what is at stake when whether therapy is worth it goes unaddressed:
What the fee actually buys
Paying privately means the clinical decisions are made between you and your clinician, with no third party reviewing whether treatment continues and no diagnosis transmitted to a payer. It also means the fee is visible rather than buried, which is the right condition for judging value. Practical questions about scheduling, matching and confidentiality are collected in answers to the questions people ask first. View our current rates here: cerevity.com/our-pricing-for-therapy/.
Session formats that fit an hour you do not have
Sessions are delivered by secure telehealth nationwide across all 50 states, and the format is part of the value calculation rather than an afterthought. Most work runs as the standard weekly session; when the material keeps getting cut off mid-thought, or travel makes a weekly slot unrealistic, the extended session format covers in one sitting what would otherwise take three. The service model at a glance sets out what can actually be booked.
§07 / 09 / Evidence
What the research shows.
The strongest claim the evidence supports is that therapy beats no therapy by a clear but moderate margin, and that who you sit with matters more than which school they trained in. Cuijpers and colleagues found no significant difference between the response rates of the different therapies they compared, ranging from 37 percent for interpersonal therapy to 46 percent for behavioral activation, with cognitive behavioral therapy at 42 percent. What does predict outcome, consistently, is the working alliance. Flückiger and colleagues synthesised 295 independent studies covering more than 30,000 patients and reported an alliance-outcome association of r = .278, holding across assessor perspectives, measures, treatment approaches, patient characteristics and countries. For a reader deciding where to spend attention, that is the practical instruction: spend it on the match, and change it early if it is wrong.
► Three numbers worth carrying into the decision
of adults treated for depression responded within about two months, against 17 percent in usual care.
Cuijpers et al., Acta Psychiatrica Scandinavica, 2021
weighted dropout rate across 669 psychotherapy studies and 83,834 clients.
Swift and Greenberg, Journal of Consulting and Clinical Psychology, 2012
alliance-outcome association across 295 studies and more than 30,000 patients.
Fluckiger et al., Psychotherapy, 2018
Two further findings belong in an honest account. First, people leave. Swift and Greenberg pooled 669 studies covering 83,834 clients and found a weighted dropout rate of 19.7 percent, about one client in five, which is the single clearest sign that a purchase decision made without a defined focus tends not to survive contact with a busy year. Second, the money question has been modelled at population scale rather than personal scale. In a global return on investment analysis published in The Lancet Psychiatry, Chisholm and colleagues estimated benefit to cost ratios of 2.3 to 3.0 for scaled-up treatment of depression and anxiety when only economic benefits are counted, rising to 3.3 to 5.7 when the value of health gains is included. That is a modelled societal return on treatment coverage across 36 countries, not a forecast for one person's course of therapy, and it should not be quoted as one. What it does establish is that treating these conditions is not a discretionary indulgence at the level of an economy, which is a reasonable prior to carry into a personal decision.
§§ / 09 / Recap
Key takeaways.
Five things to remember
- The evidence is good, not miraculous 41 percent of treated adults responded within about two months against 17 percent in usual care, and roughly one third reached remission. Worth doing, and worth going in with accurate expectations.
- The hour is the real cost For a high earner the fee is rarely the binding constraint. Fifty hours a year is, which is why a defined focus and a defined length matter more here than they do for almost any other buyer.
- Three groups should not start yet A situational problem already resolving, a want for advice rather than treatment, and a complaint with a possible medical cause all point somewhere other than a course of therapy this month.
- Set the review point before the first session Four to six sessions, one named target, one honest assessment of whether anything moved. Fit is the strongest single predictor of outcome, so a flat review is a reason to change clinician rather than to quit.
- CEREVITY provides this through online individual therapy nationwide, with full privacy through its private-pay concierge network and no insurance involvement.
§08 / 09 / FAQ
Frequently asked questions.
Is therapy worth it if nothing is seriously wrong?
Therapy is worth it when there is a specific thing you want changed, even if you are functioning well on the outside. High earners very often present with nothing that would fail a clinical screen and everything that has quietly stopped working: sleep that no longer restores, decisions that take three times as long as they used to, a home life running on the residue of the working day. That is a legitimate target for treatment. What is not a good use of money is starting with no stated problem at all, because a therapy with no target has no way to tell you whether it is working. Name the thing first. If you cannot name one, the useful first step is a single session spent working out whether there is one.
Does therapy work, and how well does it work?
Psychotherapy works for a meaningful share of people and not for everyone. In a 2021 meta-analysis of 228 randomized trials, 41 percent of adults treated for depression responded within about two months, compared with 17 percent in usual care and 16 percent on a waitlist, and roughly one third reached remission. The number needed to treat against usual care was 5.3. The same analysis found deterioration rates below 5 percent for people in therapy against 7 to 13 percent in the control conditions, so the risk of getting worse was lower in treatment than out of it. Read plainly: good odds, not certainty, and clearly better than waiting.
Is therapy worth the money for someone earning well?
Therapy is worth the money when the problem it targets is already costing more than the fee, which for high earners is usually the case long before they notice. The cost of untreated burnout and low mood does not arrive as a bill. It arrives as slower decisions, avoided conversations, a shorter fuse with the people who report to you and a partner absorbing the difference. CEREVITY clinicians look at that ledger before the fee comes up. If the honest answer is that the current situation is stable and improving on its own, the right advice is to wait, and a good clinician will say so.
Is private therapy worth it for someone who bills their time at a high rate?
Private therapy is worth it for high earners mainly because it buys control over the two variables that actually drive outcome: who you work with, and how the work is shaped. Paying privately means you can change clinician at a review point rather than waiting for a reallocation, choose a session length that fits the work rather than the slot, and keep the clinical decisions between you and your clinician. The trade is that the fee is fully visible. That visibility is an advantage for this reader, because a cost you can see is a cost you can hold to account.
How many sessions before I know whether it is working?
Four to six sessions is a reasonable point at which to make a first judgement, and the checkpoint should be agreed before the first one. The National Institute for Health and Care Excellence tells clinicians to review how well treatment is working with the person between 2 and 4 weeks after starting, and describes individual cognitive behavioural therapy for a new episode of more severe depression as usually consisting of 16 regular sessions. So the shape of a course is a few months, not a few years, and the first read comes early. What you are looking for at the review is movement on the target you named, not a transformation.
What if therapy does not work for me?
Non-response is common enough that it should be planned for rather than treated as a personal verdict. More than half the people in the pooled psychotherapy trials did not meet the response threshold, and the most frequent recoverable causes are a poor clinician match, a target that was never defined, and a method mismatched to the problem. Changing clinician is the first move, not the last resort, given how strongly the working alliance predicts outcome, and CEREVITY treats a flat review as a matching problem before it is treated as a treatment failure. Roughly one client in five leaves therapy early, and a fair share of those departures are the right decision made for the wrong reason. If two properly focused courses of treatment with different clinicians produce nothing, that is genuinely useful information about where to spend next.
How does your private-pay pricing structure work?
As a private-pay concierge network, we offer structured investments in your mental health without the restrictions or privacy risks of insurance. You can review our full fee schedule and specific session lengths directly on our website. While this costs more than insurance copays, it provides the flexibility, total privacy, and highly specialized care that standard options cannot offer. View our current rates here.
How do you protect my privacy?
Privacy is foundational to our network. As a private-pay network, your sessions never appear on insurance records or EOBs that could be seen by employers, boards, or family members. We use HIPAA-compliant nationwide telehealth platforms, and you can attend sessions from anywhere with a private internet connection.
§09 / 09 / Begin
Test it against a checkpoint, not against faith.
If you can name one thing you want different in six months, that is enough to start with and enough to judge the work against. CEREVITY is a nationwide network of independent licensed clinicians providing confidential private-pay care. Call (562) 295-6650 or send a private inquiry.
Seven days a week, early morning to late evening · Current session and support hours are on the contact page, shown in your time zone§§ / Author
About Trevor Grossman, PhD.
Trevor Grossman, PhD
Dr. Grossman is a Licensed Psychologist with more than 15 years of clinical experience working with entrepreneurs, founders, senior executives, and high-responsibility professionals navigating burnout, anxiety, and depression. His work integrates cognitive behavioral therapy, acceptance and commitment therapy, behavioral activation, and schema-informed approaches calibrated to the working week his clients are actually living in. He sees clients via CEREVITY's nationwide telehealth network. View full bio →
§§ / Sources
References.
- Cuijpers P, Karyotaki E, Ciharova M, Miguel C, Noma H, Furukawa TA, Acta Psychiatrica Scandinavica. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis. 2021. pmc.ncbi.nlm.nih.gov
- Fluckiger C, Del Re AC, Wampold BE, Horvath AO, Psychotherapy. The alliance in adult psychotherapy: A meta-analytic synthesis. 2018. pubmed.ncbi.nlm.nih.gov
- Swift JK, Greenberg RP, Journal of Consulting and Clinical Psychology. Premature discontinuation in adult psychotherapy: a meta-analysis. 2012. pubmed.ncbi.nlm.nih.gov
- National Institute for Health and Care Excellence. Depression in adults: treatment and management, NICE guideline NG222, Recommendations. 2022. nice.org.uk
- Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S, The Lancet Psychiatry. Scaling-up treatment of depression and anxiety: a global return on investment analysis. 2016. pubmed.ncbi.nlm.nih.gov
- CEREVITY. Decision fatigue therapy. cerevity.com/decision-fatigue-therapy
- CEREVITY. Executive burnout therapy. cerevity.com/executive-burnout-therapy
- CEREVITY. High-stakes anxiety therapy. cerevity.com/high-stakes-anxiety-therapy
⚠ Crisis resources
If you are experiencing a mental health crisis or having thoughts of suicide, please reach out immediately. 988 Suicide & Crisis Lifeline · Call or text 988 Crisis Text Line · Text HOME to 741741 National Alliance on Mental Illness · 1-800-950-NAMI (6264)
